Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Allison Snyder MD

Allison Snyder MD

Senior Clinical Research Fellow, Inherited Neurodegenerative Diseases Unit, Neurogenetics Branch and Behavioral Neurologist, Neurodegenerative Disorders Clinic, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland

Dr. Allison Snyder is a Senior Clinical Research Fellow in the Inherited Neurodegenerative Diseases Unit in the Neurogenetics Branch and a behavioral neurologist in the Neurodegenerative Disorders Clinic at the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.

Dr. Snyder received her medical degree from the University of Rochester School of Medicine and Dentistry in Rochester, NY and her neurology training at the University of Maryland, Baltimore, MD. She completed fellowship training in behavioral neurology at the Memory and Aging Center at UCSF under the mentorship of Drs. Bruce Miller, Howard Rosen, and Joel Kramer. Following completion of her clinical fellowship, she joined the NIH as a research fellow to develop basic science skills. Her clinical expertise is in primary progressive aphasias and other frontotemporal dementias. Her research focuses on mechanism of diseases in genetic forms of frontotemporal dementia using iPSC-derived microglia under the mentorship of Dr. Michael Ward.


Dr. Snyder has no relevant disclosures.